Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
65,732
-
Share change
-
-71,686
-
Total reported value
-
$1,258,111
-
Price per share
-
$19.14
-
Number of holders
-
2
-
Value change
-
-$1,372,070
-
Number of sells
-
2
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2023
As of 31 Dec 2023,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,732 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, GLENVIEW CAPITAL MANAGEMENT, LLC, STATE STREET CORP, EARNEST PARTNERS LLC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and DIMENSIONAL FUND ADVISORS LP.
This page lists
191
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.